AKTX vs VRTX
Akari Therapeutics PLC · Vertex Pharmaceuticals Inc
Relative return (rebased to 100)
Key stats
| Metric | AKTX | VRTX |
|---|---|---|
| Price | $7.28 | $498.50 |
| Market Cap | $1.13T | $126.35B |
| P/E | — | 31.96 |
| P/B | 60979.95 | 6.24 |
| P/S | 3082340.28 | 10.53 |
| ROE | -93.0% | 19.5% |
| Net Margin | -4702.1% | 32.9% |
| Gross Margin | — | — |
| Revenue Growth | -39.5% | 8.9% |
| Dividend Yield | — | — |
| EPS | -$0.00 | $15.60 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.